Despite what the name suggests, Polyendocrine Metabolic Ovarian Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PMOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PMOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PMOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PMOS so challenging—and why understanding your unique experience matters.
So, how can the PMOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PMOS—and make progress.
Here’s what you’ll find at PMOSA:
✅ Reliable, science-backed information about what PMOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PMOS patients
🙋♀️ Advocacy to make sure PMOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PMOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
INTRODUCTION: Animal research diets are often autoclaved for sterilization. Autoclaved chow can also serve as a model for investigating the health effects of heat-processed foods. Emerging evidence finds that heat-processed foods adversely affect human health. We hypothesized that autoclaved chow would further impair metabolism in a mouse model of androgen-induced insulin resistance.
Published on: Wed, 24 Jun 2026 06:00:00 -0400
Authors: Adelaide E Weidner, Kenji Vann, Denise Ivey, Zachary R Sechrist, Calvin L Cole, Olga Astapova,
CONCLUSION: Exposure to POPs, particularly PFOS and p,p'-DDE, was associated with elevated PCOS risk among Chinese women. Sex hormones, especially testosterone and progesterone, partially mediated these associations, suggesting hormonal disruption as a potential mechanism linking POPs exposure to PCOS.
Published on: Wed, 24 Jun 2026 06:00:00 -0400
Authors: Zekun Zhao,
CONCLUSION: This study is the first to use MR to explore causal links between lipids, inflammatory factors, and PCOS. We identified uPA as a key mediator and uncovered 11 lipids significantly associated with PCOS, highlighting the phosphatidylcholine (18:2_20:4)-uPA-PCOS pathway. Our findings suggest targeting lipid metabolism and using phosphatidylcholine (18:2_20:4) and uPA as biomarkers and tools for evaluating therapeutic efficacy in PCOS.
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Tingyu Lang, Yongxiu Yang,
CONCLUSION: JTW serves as a promising alternative therapy for multiple nervous system diseases and metabolic disorders owing to its diverse pharmacological activities, although its clinical translation remains to be established. Further research is urgently necessary to utilize integrated systems biology approaches (such as proteomics, metabolomics, and transcriptomics) for elucidating the intricate mechanisms of JTW and uncovering the biological basis that underlies the synergistic effects of...
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Fengwei Nan, Wangjun Xu, Xian Wang, Qinghe Miao, Jingwei Sun, Ran Zhao, Xi Li, Yunfeng Zhou, Xinmei Xie, Xiaobin Pang,
CONCLUSIONS: Current evidence indicates a possible modest association between PMOS/PCOS and breast cancer risk, although findings remain inconclusive. Any absolute increase in risk appears limited and does not justify changes to current screening practices. Further research using standardized diagnostic criteria and improved stratification by phenotype, age, and menopausal status is warranted.
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Flavia Costanzi, Stefano Palomba, Giuseppe Seminara, Aris Raahd Besharat, Donatella Caserta,
No abstract
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Nisreen Khaled Aref, Waleed Ali Sayed Ahmed, Magdy Refaat Ahmed, Wael Farouk Sedik,
CONCLUSION: This observational pilot study suggests that a pre-treatment with 3.6:1 MYO:DCI ratio and antioxidant-based supplement taken for at least 1 month prior to ovarian stimulation may improve oocyte quality and increase pregnancy rates. These findings, while promising, require confirmation in larger prospective trials.
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Pedro Belchín Fernández, Virginia Calvente, Maria Jose Gómez Roso, Eva González Expósito, Ana Silván Bueno, Maya Aparicio Fluge, Daniel Ordoñez Pérez,
STUDY QUESTION: Do gestational weight gain trajectories and risk of gestational diabetes mellitus (GDM) differ according to the underlying fecundability and use of ART?
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: A S D Laursen, E M Mikkelsen, V R Mitter, M C Magnus,
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder with complex pathophysiology involving reproductive and metabolic dysfunctions. This study investigates the therapeutic potential of Mondia whitei, a traditional African medicinal plant, against PCOS using an integrative in silico approach combining network pharmacology, molecular docking, and quantitative structure-activity relationship (QSAR) modelling. Fifteen bioactive phytochemicals from M. whitei were retrieved from...
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Akingbolabo Daniel Ogunlakin, Owona Pascal Emmanuel, Christopher B Olowosoke, Adeleye Adegboyega Edema, Ahamefula Ansalm Ahuchaogu, Caleb Joel Nwaogwugwu, Seun Elizabeth Kuyoro, Abdullahi Adeyemi Adegoke, Tope Abraham Ibisanmi, Mubo Adeola Sonibare, Enitan Omobolanle Adesanya, Ajibola David Adelakun, Oluwafemi Adeleke Ojo, Mojisola Abosede Bayode, Oluyomi Stephen Adeyemi,
CONCLUSION: VAI is a practical, non-invasive tool for identifying metabolic dysfunction and predicting adverse pregnancy outcomes in women with PCOS, supporting its use for risk stratification and early intervention.
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Baichao Shi, Jiaxing Feng, Fengjuan Lu, Muxin Guan, Jiannan Yu, Zhuwei Gao, Yu Wang, Jing Cong, Hongli Ma, Conghui Han, Wen Yang, Xiaoke Wu, Jingshu Gao,
CONCLUSION: GDM is highly prevalent among pregnant women attending tertiary care facilities in Bangladesh. Advanced maternal age, positive family history of diabetes, and PCOS are important independent predictors. Early risk-based screening and preventive interventions may help reduce maternal and fetal complications associated with GDM.
Published on: Tue, 23 Jun 2026 06:00:00 -0400
Authors: Mohammad Moin Shahid, Khadija Begum, Kaniz Rahman, Kaniz Fatema, Fatema Tuj Johora,
CONCLUSION: This model highlights the role of IVM as a valuable component of PCOS infertility treatment in centres of expertise, with potential for greater impact as culture systems advance.
Published on: Mon, 22 Jun 2026 06:00:00 -0400
Authors: Linde Mostinckx, Neli Hofer, Max Lelie, Shari Mackens, Ingrid Segers, Katrien Beeckman, Michel De Vos,
Polycystic ovary syndrome (PCOS) implicates hormonal imbalance, ovulation disorders, metabolic disturbances, and chronic low-grade inflammation. In this study, we investigated the inflammation driven by 12-lipoxygenase (12-LOX)-mediated conversion of arachidonic acid to pro-inflammatory 12-hydroxyeicosatetraenoic acid (12-HETE) and the therapeutic potential of avenanthramide (AVA)-enriched oat extract and trans-resveratrol (RSV) as natural 12-LOX inhibitors. AVA-enriched extract was obtained...
Published on: Mon, 22 Jun 2026 06:00:00 -0400
Authors: Yara Walid, Raghda A Elsabbagh, Heba Handoussa, Sahar M Abdel-Maksoud,
CONCLUSION: Breastfeeding is associated with a significant reduction in long-term cardiometabolic risks in women with PCOS following complicated pregnancies. Supporting and optimizing lactation may represent a valuable non-pharmacological strategy to consider for this high-risk population.
Published on: Mon, 22 Jun 2026 06:00:00 -0400
Authors: Stefano Palomba, Giuseppe Seminara, Flavia Costanzi, Rossella Cannarella, Tiziana Russo, Fabrizio Signore, Martina Sarica, Aldo E Calogero, Donatella Caserta, Antonio Aversa,
[This corrects the article DOI: 10.3389/fmed.2026.1730795.].
Published on: Mon, 22 Jun 2026 06:00:00 -0400
Authors: Yingchun Lv, Dongqi Li, Ning Ding, Hongying Kuang,